MMWR. 2004;53:Q1-Q4
CDC’s Advisory Committee on Immunization Practices (ACIP) annually reviews the recommended Adult Immunization Schedule to ensure that the schedule reflects current recommendations for the use of licensed vaccines. In June 2004, ACIP approved the Adult Immunization Schedule for October 2004–September 2005. This schedule has also been approved by the American Academy of Family Physicians and the American College of Obstetricians and Gynecologists.
Changes in the Schedule for October 2004–September 2005
The 2004–2005 schedule differs from the previous schedule as follows:
- Both figures now provide a separate row for each vaccine (Figure 1 and Figure 2).
- Health-care workers have been added to the figure that provides immunization recommendations by medical indications and other conditions (Figure 2).
- The special note regarding influenza vaccination of pregnant women reflects the revised ACIP recommendations that all pregnant women should receive influenza vaccination regardless of preexisting chronic conditions.1
Health-care workers were added to the Adult Immunization Schedule in response to provider requests; this change should facilitate assessment of the vaccination status of healthcare workers and administration of needed vaccinations. In 2002, 38.4% of health-care workers reported influenza vaccination, and 62.3% reported having completed hepatitis B vaccination series (National Health Interview Survey, CDC, unpublished data, 2003). Influenza vaccination of health-care workers is an important preventive measure for persons at high risk for complications from influenza infection. Health-care workers involved in direct patient care are among the priority groups recommended to receive influenza vaccination for the 2004–05 influenza season, despite the vaccine shortage.2
The Adult Immunization Schedule is available in English and Spanish at http://www.cdc.gov/nip/recs/adult-schedule.htm. General information about adult immunization, including recommendations concerning vaccination of persons with human immunodeficiency virus (HIV) and other immunosuppressive conditions, is available from state and local health departments and from the National Immunization Program at http://www.cdc.gov/nip. Vaccine information statements are available at http://www.cdc.gov/nip/publications/vis. ACIP statements for each recommended vaccine can be viewed, downloaded, and printed from CDC’s National Immunization Program at http://www.cdc.gov/nip/publications/acip-list.htm. Instructions for reporting adverse events after vaccination to the Vaccine Adverse Event Reporting System (VAERS) are available at http://www.vaers.org or by telephone, 800-822-7967.
References: 2 available
